DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock

DSS Inc., a 10% owner of Impact Biomedical Inc. (IBO), sold a total of $1,686 worth of the company's common stock in late September 2026. The shares were traded on three separate days, with prices ranging from $0.55 to $7.0587 per share.

On September 22, DSS Inc. sold 723 shares at $0.55 each. The following day, 27 shares were sold at $6.95 per share. The final sale occurred on September 24, 2026, with 156 shares at an average price of $7.0587 per share.

The stock's recent volatility is evident, as shares are currently trading at $5.65, marking a 24% drop over the past week. After these transactions, DSS Inc. retains ownership of 589,518 shares of IBO common stock.

According to InvestingPro analysis, the company's stock appears overvalued with a market capitalization of $56.65 million. For those interested in a more detailed analysis, the platform provides 11 ProTips and comprehensive financial metrics to further explore the situation.